/Companies

Ironwood Pharmaceuticals

Cambridge, US · Delaware corporation · 6 known investors

Find your way into Ironwood Pharmaceuticals

Sign up to see every warm intro you have to Ironwood Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ironwood Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.

Founders & leadership

PMPETER M. HECHT
PETER M. HECHTFounder
MGMARK G. CURRIE
MARK G. CURRIEDirector Board Of DirectorsVenture Partner at Iaso Ventures
HEHALLEY E. GIBLERT
HALLEY E. GIBLERTExecutive
TG
THOMAS GRANEYExecutive
TATHOMAS A. MCCOURT
THOMAS A. MCCOURTExecutiveThomas A. McCourt is an executive officer at Ironwood Pharmaceuticals with over 30 years of pharmaceutical industry experience, including senior leadership roles in strategic marketing, brand management, and commercial development for multiple drug franchises and partnerships across major pharmaceutical companies.

Board

TGTERRANCE G. MCGUIRE
TERRANCE G. MCGUIREBoard directorGeneral Partner at Polaris Partners
LS
LAWRENCE S. OLANOFFBoard director
EP
EDWARD P. OWENSBoard director
JM
JULIE MCHUGHBoard director
MH
MARSHA H. FANUCCIBoard director
DE
DOUGLAS E. WILLIAMSBoard director
CT
CHRISTOPHER T. WALSHBoard director

Investors · 6

Reported raises · per SEC filings

Form D private placements

$150M disclosed across 1 round · 2016

▶$150MraisedOct 2016 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • LAWRENCE S. OLANOFFDirector
  • TERRANCE G. MCGUIREDirector
  • MARK G. CURRIEExecutive Officer
  • EDWARD P. OWENSDirector
  • JULIE MCHUGHDirector
  • HALLEY E. GIBLERTExecutive Officer
  • PETER M. HECHTExecutive Officer, Director
  • MARSHA H. FANUCCIDirector
  • THOMAS GRANEYExecutive Officer
  • DOUGLAS E. WILLIAMSDirector
  • CHRISTOPHER T. WALSHDirector
  • THOMAS A. MCCOURTExecutive Officer
  • ANDREW DREYFUSDirector
Offering amount
$150M
Amount sold
$150M
Sales commissions
$20K
Finders' fees
$20K
Placement agents
J. WOOD CAPITAL ADVISORS
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Ironwood Pharmaceuticals.

In the news

Frequently asked questions

What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases. It concentrates on GI drug discovery and care for patients suffering from digestive diseases.
Who founded Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals was founded by PETER M. HECHT.
Who are Ironwood Pharmaceuticals's investors?
Ironwood Pharmaceuticals's investors include F-Prime Capital, Mountain Group Capital, Ridgeback Capital, Venrock, Maverick Ventures, Polaris Partners.
How much funding has Ironwood Pharmaceuticals raised?
Ironwood Pharmaceuticals has disclosed $150M raised across 1 round.
Where is Ironwood Pharmaceuticals headquartered?
Ironwood Pharmaceuticals is headquartered in Cambridge, US.